2015student hba conf program lr 2.6

Modernizing Healthcare for

the New Age

1ST ANNUAL UCLA HBA HEALTHCARE CONFERENCEFRIDAY, FEBRUARY 13, 2015

UCLA CARNASALE COMMONS

http://on.fb.me/1DKCF7M

http://linkd.in/1Icq2sp

#UCLAModernHealth2015

andersonhba.com

CONNECT WITH US!

2 | HBA Healthcare Conferece

» WELCOME FROM THE DEAN

» WELCOME FROM HBA PRESIDENT

Welcome to the inaugural UCLA HBA Healthcare Conference, beginning a tradition that we envision as an annual event.

This first edition focuses on “Modernizing Healthcare for the New Age.” UCLA is the ideal setting for an interdisciplinary healthcare summit. Beyond the resources available at Anderson, UCLA features world-class professional schools in medicine, public policy, public health, engineering, life sciences, and nursing, offering unique opportunities to exploit broad expertise from across campus. There are vital life, and market-changing opportunities and challenges in healthcare today, including shrinking reimbursement

rates, expensive yet transformative biologics, declines in federal funding of research, care for a growing aging population, breakthroughs in medical devices and personalized medicine, genomic advances and the exciting possibilities of telemedicine and mobile health.

Today’s conference will do a deep dive into all of these topics, and more. I hope you come away from the day with a new lens into these weighty and transformative opportunities.

We are privileged to welcome a stellar group of presenters and panelists from both UCLA and other healthcare organizations.

And please let me acknowledge (and brag about) the student organizers from UCLA Anderson’s Healthcare Business Association. They recognized the need for today’s conference, seized the initiative, and poured energy into this conference. But of course. They Think In The Next!

Sincerely,

Judy D. Olian Dean and John E. Anderson Chair in Management UCLA Anderson School of Management

Dear Classmates, Alumni and Friends of UCLA Anderson:

On behalf of the Healthcare Business Association Conference Committee, as President of the HBA, I welcome you to the 1st Annual UCLA Anderson HBA Healthcare Conference: Modernizing Healthcare for the New Age. I am delighted that you are joining us today as I hope this event will become a long-standing tradition, not only at Anderson, but within the greater UCLA and Los Angeles communities.

This era of healthcare is more dynamic than ever before: mobile health is attracting unprecedented investments by private investors, personalized medicine is now a national conversation, and health reform legislation is settling in as the new normal. This conference aims to explore the evolution of the healthcare industry and how it has, and will, adapt to meet the needs of modern times.

Our keynote speakers, panels, and networking opportunities will allow you to join in and become a participant in this important conversation. I hope this conference will inspire you toward greater understanding and further exploration of the topics discussed today.

I want to extend a personal thank you to our speakers and moderators for enriching the discussion with their expertise and insights, to our sponsors for their generous support, and to UCLA Anderson’s administration for enabling us to host such a multidisciplinary event. Finally, I would like to thank all the attendees, because without you the purpose of the event, strengthening and educating the UCLA and Southern California healthcare communities, would not be possible.

Sincerely,

Subodh Kolla President Healthcare Business Association

Friday, February 13, 2015 | 3

» SCHEDULE

8:00 – 9:00 a.m. REGISTRATION & BREAKFAST

9:00 – 9:55 a.m. WELCOME & OPENING REMARKS Palisades Room A/B/C/F Subodh Kolla, Healthcare Business Association, President Judy Olian, Dean and John E. Anderson Chair in Management, UCLA Anderson School of Management David Feinberg, M.D., MBA, President, UCLA Health System, CEO, UCLA Hospital System, Associate Vice Chancellor, UCLA Health Sciences

MORNING KEYNOTE Palisades Room A/B/C/F Neil Solomon, M.D., FACP, Vice President for Quality and Care System Transformation, Blue Shield of California

10:15 – 11:00 a.m. PANEL 1: PAYER/PROVIDER Palisades Room: D/E Maneesh Goyal (’06), Senior Vice President of Corporate Development, Welltok, Inc. Martin Serota, M.D., Vice President and Chief Medical Officer, AltaMed Health Services Arthur Southam, M.D., MPH, MBA, Executive Vice President of Health Plan Operations, Kaiser Foundation Health Plan, Inc. MODERATOR: Mike Galper, MPH, Partner, PwC

PANEL 2: EMERGING MARKETS Hermosa A/B Michele Abbott, Assistant Policy Analyst, RAND Corporation Michael Burke, M.H.A., Director of Business Development, UCLA Center for World Health Ninez Ponce, MPP, Ph.D., Director of the Center for Global and Immigrant Health, UCLA Fielding School of Public Health MODERATOR: Eric Savitsky, M.D., Founder and Executive Director, UCLA Center for International Medicine

11:15 a.m. – 12:00 p.m. PANEL 3: MED-TECH/BIO-DEVICE Hermosa A/B Paul Grand, Managing Director, RCT Ventures Abhra Roy, M.S., MBA (’10), Vice President, Mechanical Engineering & Material Science Research & Development, St. Jude Medical Meera Shier (’09), Marketing Manager, MicroVention Inc. MODERATOR: Jennifer McCaney, Ph.D., Senior Fellow, UCLA Business of Science Center

PANEL 4: PERSONALIZED MEDICINE Palisades Room D/E David Chang, M.D., Executive Vice President, Research and Development, and Chief Medical Officer, Kite Pharma Sudheer Doss, Ph.D., Director, PwC Jill Hagenkord, M.D., FCAP, Chief Medical Officer, 23andMe Alexander Hoffmann, Ph.D., Professor, Microbiology and Immunology, UCLA, Director, Institute for Quantitative and Computational

Biosciences MODERATOR: Eric Vilain, Ph.D., Professor of Human Genetics, Pediatrics and Urology at UCLA,

Co-Director, Institute for Society and Genetics, Chief of Medical Genetics, UCLA

12:15 – 1:15 p.m. LUNCH & MIDDAY KEYNOTE Palisades Room A/B/C/F Introduction by: Eric Esrailian, M.D., MPH, Co-Chief of the Division of Digestive Diseases, David Geffen School of Medicine at UCLA Peter H. Diamandis, M.D., Chairman and CEO, X Prize Foundation

1:30 – 2:15 p.m. PANEL 5: MOBILE HEALTH Hermosa A/B Ilana Muhlstein, Registered Dietitian Nutritionist, UCLA Bruin Health Improvement Program Kourosh Parsapour, M.D., MBA, CEO, personalRN David J. Whelan, MBA (’02), Co-Founder, STEMP Inc. MODERATOR: Mark Schwartz, Founder, Launchpad Digital Health

PANEL 6: POLICY Palisades Room D/E Albert Lowey-Ball, Ph.D., Health Economics and Medicaid Advisor, UC Berkeley School of Public Health Jonathan Fielding, M.D., MPH, MBA, Director and Professor-in-Residence, UCLA Fielding School of Public Health Wendy Schiffer, MSPH, Director of Strategic Planning, L.A. Care Health Plan MODERATOR: Wesley Yin, Ph.D., Associate Professor, UCLA

2:30 – 3:15 p.m. PANEL 7: BIOPHARMA Hermosa A/B Stephanie Astrow, Ph.D., MBA, Vice President of Research and Development, Response Genetics Gunjan (Mital) Thiagarajah, MBA (’05), Marketing Director, Amgen Brian Williams, Director, PwC MODERATOR: Bill Comanor, Ph.D., Professor of Health Policy and Management, Professor of Economics, UC Santa Barbara

Director, Research Program on Pharmaceutical Economics and Policy, UCLA

PANEL 8: BABY BOOMER SILVER TSUNAMI Palisades Room D/E Sandy Atkins, MPA, Vice President of Strategic Initiatives, Partners in Care Foundation Scott Kaiser, M.D., Chief Innovation Officer, Motion Picture & Television Fund Carol Lee Thorpe, MBA, Vice President of Programs and Services, St. Barnabas Senior Services MODERATOR: Arash Naeim, M.D., Ph.D., Chief Medical Officer of Clinical Research and Geriatric Oncologist, UCLA Health

3:30 – 4:15 p.m. CLOSING FIRESIDE CHAT Palisades Room A/B/C/F Thomas Priselac, MPH, President and CEO, Cedars-Sinai Health System MODERATOR: Leah Vriesman, Ph.D., MPH, MBA, Director, UCLA Executive Education in Health Policy & Management

4:30 – 5:30 p.m. NETWORKING COCKTAIL RECEPTION Covel Commons Terrace

4 | HBA Healthcare Conference

» KEYNOTE SPEAKER BIOGRAPHIES

» WELCOME & OPENING REMARKSJUDY D. OLIAN, PH.D. Dean and John E. Anderson Chair in Management UCLA Anderson School of ManagementJudy D. Olian, Ph.D., is the eighth dean of UCLA Anderson School of Management and John E. Anderson Chair in Management. She began her appointment in January 2006 after serving as

dean and professor of management at the Smeal College of Business Administration at Pennsylvania State University, and professor and senior associate dean at the Smith School at the University of Maryland.

Under her leadership, UCLA Anderson has hired a record number of faculty, launched new global degree and certificate programs, and initiated and developed targeted partnerships in Asia and Latin America. Recently, UCLA Anderson transitioned into a new financial model for the University of California. Under her leadership, the School has raised almost $200 million to support innovative programming and management thought leadership, and to advance UCLA Anderson as one of the leading schools of management in the world.

Dean Olian leads a school that annually provides management education to almost 2,000 students and to more than 2,000 professionals through executive education programs. The school has several widely recognized research centers and a global alumni network of more than 35,000 graduates.

She is a sought-after speaker and has consulted for major corporations. She serves on the advisory boards of Catalyst, the U.S. Studies Centre at the University of Sydney, the Westwood Technology Transfer and Ares Management.

Dean Olian holds an undergraduate degree from the Hebrew University, Jerusalem, and a Ph.D. from the University of Wisconsin, Madison.

DAVID T. FEINBERG, M.D., MBA President, UCLA Health System, CEO, UCLA Hospital System, Associate Vice Chancellor, UCLA Health SciencesDr. David T. Feinberg has been CEO of UCLA’s hospitals and associate vice chancellor of UCLA Health Sciences since 2007. In July 2011, he assumed the position of president of UCLA

Health System, overseeing its four hospitals — Ronald Reagan UCLA Medical Center, Stewart and Lynda Resnick Neuropsychiatric Hospital at UCLA, Mattel Children’s Hospital UCLA and UCLA Medical Center, Santa Monica — and the UCLA Faculty Practice Group. Each year, UCLA’s hospitals treat more than 40,000 patients, and 1.5 million patients are seen in UCLA’s 150 community offices. Ronald Reagan UCLA Medical Center and UCLA Medical Center, Santa Monica, are ranked No. 5 in the nation by U.S.News & World Report, and Ronald Reagan UCLA Medical Center has been ranked “Best in the West” for 25 consecutive years.

Modern Healthcare named him among the “50 Most Influential Physician Executives and Leaders” in the United States for 2014. Dr. Feinberg is a clinical professor of psychiatry in the David Geffen School of Medicine at UCLA.

Along with his dedication to upholding the highest clinical standards for patient care and safety, Dr. Feinberg is committed to enhancing the patient experience. Under his leadership, patient-satisfaction scores have reached the 99th percentile in many areas.

» MORNING KEYNOTENEIL SOLOMON, M.D., FACP Vice President for Quality and Care System TransformationDr. Neil Solomon joined Blue Shield of California (BSC) as the vice president for Quality and Care System Transformation in April 2013. In that role, he is responsible for designing and implementing the clinical

quality strategy for the membership. His work in quality spans BSC’s industry leading Accountable Care Organizations, specialty care transformation, and the use of health information technology to enable improvements in care. Under his direction, the Quality Department also evaluates and rewards performance among Blue Shield’s provider community, introduces programs to improve clinical outcomes and member experience, and reports these findings to customers and regulators.

Prior to joining BSC, Dr. Solomon held leadership roles at Health Net, a Western Region health plan based in California. His previous roles included chief medical director, senior medical director for commercial ACO development and clinical accounts management, chair of the Medical Policy Committee and lead physician for quality, disease management and case management.

Earlier in his career, Dr. Solomon co-founded and was the clinical director for the Care Management Institute, Kaiser Permanente’s internal system-wide think tank regarding population management, disease management and quality improvement. He founded NAS Consulting Services, a California-focused QI consulting firm that worked with medical groups, delivery systems and health plans on quality and service improvement. He was also CEO for the Institute for Medical Knowledge Implementation, a nonprofit that created interoperable clinical decision support rules and a community of rule writers and implementers.


» KEYNOTE SPEAKER BIOGRAPHIES

» LUNCH & MIDDAY KEYNOTEIntroduction by ERIC ESRAILIAN, M.D., MPH Co-Chief of the Division of Digestive Diseases, David Geffen School of Medicine at UCLADr. Esrailian is the co-chief of the Division of Digestive Diseases at the David Geffen School of Medicine at UCLA. Dr. Esrailian’s primary clinical interests include gastrointestinal

endoscopy, inflammatory bowel diseases, gastrointestinal hemorrhage and functional gastrointestinal diseases such as irritable bowel syndrome. In addition to disease areas within gastroenterology and internal medicine, Dr. Esrailian has a particular interest in the development of biomedical innovations, value in healthcare, medical education and initiatives toward patient-centered care.

In 2012, the School of Medicine awarded him the Lincy Foundation Chair in Clinical Gastroenterology. He is closely involved in growth strategy and strategic planning efforts for UCLA Health and the David Geffen School of Medicine at UCLA. He also works to facilitate community engagement with a number of other schools and departments within the UCLA campus and its Los Angeles community partners, and he is on the UCLA campus steering committee for the Centennial Campaign.

PETER H. DIAMANDIS, M.D. Chairman and CEO, X Prize FoundationDr. Peter H. Diamandis is an international pioneer in the fields of innovation, incentive competitions and commercial space. In the field of innovation, Diamandis is chairman and CEO of the X PRIZE Foundation, best known for its $10 million Ansari X PRIZE for private

spaceflight. Today, the X PRIZE leads the world in designing and operating large-scale global competitions to solve market failures.

Diamandis is also the co-founder and vice chairman of Human Longevity Inc. (HLI), a genomics and cell therapy-based diagnostic and therapeutic company focused on extending the healthy human lifespan. He is also the co-founder and executive chairman of Singularity University, a graduate-level Silicon Valley institution that studies exponentially growing technologies, their ability to transform industries and solve humanity’s grand challenges.

He earned an undergraduate degree in molecular genetics and a graduate degree in aerospace engineering from Massachusetts Institute of Technology, and received his M.D. from Harvard Medical School. Diamandis’ mission is to open the space frontier for humanity. His personal motto is, “The best way to predict the future is to create it yourself.”

» CLOSING FIRESIDE CHATTHOMAS PRISELAC, MPH President and CEO, Cedars-Sinai Health SystemThomas Priselac has served as president and CEO of the Cedars-Sinai Health System since 1994 and is an adjunct professor at UCLA Fielding School of Public Health. Priselac was executive vice president from 1988 to 1993 and has been associated with Cedars-Sinai since 1979.

Priselac is a past chair of the American Hospital Association (AHA) Board of Trustees, Association of American Medical Colleges (AAMC), California Healthcare Association and the Healthcare Committee of the Los Angeles Chamber of Commerce. Additionally, he served on the Board of Directors of VHA, Inc., the National Committee for Quality Healthcare, the California Healthcare Foundation and Blue Cross of California. He lectures extensively at professional meetings and universities on varied aspects of healthcare delivery and leadership.

A native of Pennsylvania, he obtained a bachelor’s in biology from Washington and Jefferson College in Pennsylvania and a master’s in public health, health services administration and planning from the University of Pittsburgh.

MODERATOR LEAH VRIESMAN, PH.D. MPH, MBA, Director, UCLA Executive Education in Health Policy & ManagementLeah Vriesman is director of executive education programs in health policy and management and is on the faculty of UCLA’s School of Public Health in the Department of Health Policy & Management.. She

teaches strategic management of health service organizations, healthcare marketing, international comparative health systems and, occasionally, healthcare financial management.

Dr. Vriesman is also an adjunct professor at the University of Colorado–Denver, teaching pharmaceutical marketing management, and an experienced distance learning faculty member for strategic and operational healthcare excellence and also health communication techniques.

Dr. Vriesman is also president and founder of Excel Research, LLC, a healthcare management and policy consulting firm. Specializing in the pharmaceutical and biotechnology industries, Excel Research primarily conducts executive leadership, strategic analysis and market trend projections. Prior to founding Excel Research, Dr. Vriesman was senior director of North American Business Development within the Medical Technology Practice at The Lewin Group, an international health policy and research corporation, and subsidiary of Quintiles Transnational.

Dr. Vriesman received her Ph.D. in health services research from UCLA and her MHA and MBA in strategy from the University of Minnesota-Minneapolis.


» PANELIST BIOGRAPHIES

» PANEL 1: PAYER/PROVIDER

With the second round of Open Enrollment almost closed, panelists explore what’s in store for California’s payers and providers and the new, innovative opportunities for consumer-focused delivery.

MANEESH GOYAL (’06) Senior Vice President of Corporate Development, Welltok, Inc.Maneesh Goyal joined Welltok in early 2013 as vice president of corporate development. His responsibilities include all partnership, alliances and M&A activity related to building out the company’s CaféWell Connect ecosystem. Prior to

Welltok, Goyal was a managing director with Miramar Venture Partners, a leading early stage investor focusing on the information technology space.

With Miramar, Goyal invested in health and consumer Internet companies and provided strategic guidance for companies moving from the startup to growth stage. Before entering the venture world, he was a design engineer with Broadcom, leading product development and engineering efforts in the television, cable and satellite communication markets.

Goyal earned a bachelor’s in biomedical engineering from Worcester Polytechnic Institute, a master’s in electrical engineering from the University of Southern California and an MBA from UCLA Anderson.

MARTIN SEROTA, M.D., Vice President and Chief Medical Officer, AltaMed Health ServicesDr. Martin Serota joined AltaMed Health Services as vice president and chief medical officer in May 2010. He has practiced medicine for more than 25 years, while also assuming many leadership roles, including medical group, IPA and accountable care

organization leadership and development. He also has extensive health information technology expertise. At AltaMed, Dr. Serota’s priorities are to create a patient-centered organization that is focused on the patient experience and quality outcomes. His goals are to improve operational efficiency, especially through the use of health information technology and innovation, thereby allowing AltaMed to care for more of the underserved and to reduce health outcome disparities. Dr. Serota obtained his medical degree at University of California, San Francisco, and is board-certified in internal medicine.

ARTHUR SOUTHAM, M.D., MPH, MBA Executive Vice President of Health Plan Operations, Kaiser Foundation Health Plan, Inc.Arthur M. Southam, M.D., is executive vice president of Health Plan Operations for Kaiser Foundation Health Plan, Inc., and Kaiser Foundation Hospitals. Dr. Southam has national responsibility for health plan marketing, sales,

service and administrative activities that support growth and customer service. Before joining Kaiser Permanente in 2001, Dr. Southam was CEO of two California-based health plans, Health Net and CareAmerica. Dr. Southam serves as vice chairman of the Board of Directors of CHRISTUS Health, an international Catholic health system based in Irving, Texas. He is a member of the Board of the Council for Affordable Quality Healthcare and on the Board of Advisors of the Fielding School of Public Health at UCLA. He has also served as a member of the Institute of Medicine’s Committee on the Quality of Health Care in America. He is a past chairman of the California Association of Health Plans. Dr. Southam received his medical degree and master’s in public health from UCLA and his MBA from Pepperdine University.

MODERATOR MIKE GALPER, MPH Partner, PwCMichael Galper is a partner in the Los Angeles office of PwC and leads the West Coast Health Services Practice. He has held a variety of leadership positions over the years with the firm, including leading the National Health Insurance

Practice. Galper’s clients include integrated health systems, managed care companies, hospitals, physician groups and academic medical centers. He specializes in performance improvement, cost reduction, financial analysis, acquisition due diligence and internal control review. Galper is an adjunct faculty member at the UCLA School of Public Health and also serves as the chairman of the board for Hathaway Sycamores, a child and family service agency.



NINEZ PONCE, MPP, PH.D. Director of the Center for Global and Immigrant Health, UCLA Fielding School of Public HealthNinez A. Ponce, MPP, Ph.D., is a professor in the UCLA Fielding School of Public Health’s Department of Health Policy and Management and director of the Center for Global and Immigrant Health. She is the principal investigator

for the California Health Interview Survey, the largest state health survey in the nation. She led pioneering efforts in the measurement of race/ethnicity, the implementation of the Asian ethnic oversamples and the cultural and linguistic adaptation of the survey. A health economist, her research contributes to the elimination of racial/ethnic and social disparities in health and healthcare in three areas: multicultural survey research, social penalties in health access, and global and immigrant health.

MODERATOR ERIC SAVITSKY, M.D. Founder and Executive Director, UCLA Center for International MedicineUCLA professor of emergency medicine and pediatric emergency medicine and director of trauma services and education, Dr. Eric Savitsky is the founder and executive director of the UCLA

Center for International Medicine.

An innovative educator and inventor, Dr. Savitsky has developed multiple patent-pending inventions in the medical training and health technology sector. He is a leading medical educator and clinician, serves on the advisory boards of UCLA’s Center for Advanced Surgical and Interventional Technology and Business for Diplomatic Action, and is a member of the Pacific Council on International Policy. Dr. Savitsky received his M.D. from the University of Florida and completed his residency and a fellowship in pediatric emergency medicine at UCLA. He received a bachelor’s in Russian from the University of Florida and is conversant in English, Russian, Farsi and Spanish.

» PANEL 2: EMERGING MARKETS

A global look into new opportunities and challenges in emerging markets across both for-profit and nonprofit healthcare sectors.

MICHELE ABBOTT Assistant Policy Analyst, RAND CorporationMichele Abbott is an assistant policy analyst at RAND and a doctoral candidate at the Pardee RAND Graduate School. Prior to RAND, she worked at Abt Associates on USAID-funded HIV/AIDS and malaria prevention projects, primarily in East Africa. At Abt, her technical focus was in

costing, cost-effectiveness and other modeling analyses to inform health financing and policy decisions. She also analyzed a dataset provided by the Global Fund to monetize the private sector’s in-kind contributions to grant programs at the country level. Previously, Abbott served as a research fellow for the Center for Health Information and Decision Systems at the University of Maryland and holds a bachelor’s in international business and a minor in English.

MICHAEL BURKE, M.H.A. Director of Business Development, UCLA Center for World HealthMichael Burke is the director of international development for UCLA Health and the Center for World Health. He is responsible for seeking out and vetting potential partnership opportunities for the medical enterprise in addition to advancing

existing partnerships and collaborations. Burke joined UCLA Health as one of the 2012-2013 UCLA Administrative Fellows, when his worked focused largely on value and performance improvement initiatives. He received his undergraduate degree in finance and his master’s in health administration from the University of Iowa. His graduate program included an internship at Kameda Medical Center in Kamogawa-shi, Japan, where he focused on joint commission international preparation, pain assessment and awareness and assessment of international patient traffic. Additionally, he worked in the department of health management and policy at the University of Iowa, developing a strategic plan for inpatient and outpatient geriatric service lines at University of Iowa Hospitals and Clinics.



» PANEL 3: MED-TECH & BIO-DEVICE

A look at the biggest opportunities in med-tech over the next five years, including a discussion on MEMS technology and telehealth’s impact on patient care.

PAUL GRAND Managing Director, RCT VenturesPaul Grand has more than 25 years of experience in venture capital and the founding and management of early stage companies in technology and healthcare. He is responsible for sourcing RCT Ventures’ investments in medical devices and representing RCT on the boards of its

portfolio companies. Since 1990, Grand has built, operated, recruited management and raised financing for eight high-technology, medical device and biotechnology companies.

Grand is actively involved in programs to encourage innovation and technology commercialization and is a frequent speaker, moderator and panelist at healthcare conferences. He serves as producer and emcee for the MedTech Innovator competition, which identifies and rewards outstanding early stage medical device companies. Grand is on the oversight committees for the Coulter Translational Research Partnership Programs at USC and University of Washington. He has lectured, served as a reviewer for proof of concept and commercialization-focused funding programs, and mentored students and scientists at numerous universities, including UCLA, Stanford, USC, UCSF, University of Utah, the Keck Graduate Institute and University of Colorado. Grand served as an investment advisor to the LARTA NIH Commercialization Assistance Program for SBIR program awardees.

ABHRA ROY, M.S., MBA (’10) Vice President, Mechanical Engineering & Material Science Research & Development, St. Jude MedicalAbhra Roy is the vice president of research and development (leading mechanical and materials development) at St. Jude Medical. Recognized amongst Fortune’s most admired companies, St. Jude Medical is a global leader in the MedTech

space, focused on delivering leading-edge cardiovascular and neuromodulation therapy solutions. Roy has been with St. Jude for 13 years and has served in several leadership roles within research and development, program management and operations. Roy holds an M.E./ M.S. from Stanford and an MBA from UCLA Anderson.

MEERA SHIER (’09) Marketing Manager, MicroVention Inc.Meera Shier, marketing manager at MicroVention Inc., started her career in the financial services industry at Kayne Anderson Rudnick Investment Management. After graduating with an MBA from UCLA Anderson in 2009, Shier switched her focus to medical devices and joined the marketing team at

Covidien Neurovascular as an associate product manager. In 2013, Shier joined Microvention Inc. and currently manages a team and several product lines.

MODERATOR JENNIFER MCCANEY, PH.D. Senior Fellow, UCLA Business of Science CenterJennifer McCaney, Ph.D., is a senior fellow at the UCLA Business of Science Center (BSC), which sponsors the MedTech Innovation (MTI) Program for entrepreneurship in medical device design as well as assists university faculty and physicians in

commercializing their research through the annual Venture Team Competition. McCaney holds a lecturer position at UCLA Anderson, where she teaches a course on emerging technologies in healthcare, and is an instructor for the MTI Program in the Department of Bioengineering at UCLA. McCaney is a co-founder of Hourglass Technologies, Inc., which developed the TRIMTM System, a nonsurgical obesity device. She holds three patents and is the author of multiple peer-reviewed publications. Her interests include regenerative medicine, MEMS and microfluidics devices for biological applications, and new venture formation. A Fulbright scholar, McCaney completed her Ph.D. in mechanical engineering at Stanford and holds a master’s and undergraduate degrees from MIT and the Sloan School of Management. She also has a master’s in biomedical engineering from the University of New South Wales. Prior to joining the BSC, McCaney worked as a consultant to biotech and pharmaceutical companies at Clarion Healthcare in Boston.



» PANEL 4: PERSONALIZED MEDICINE

DAVID CHANG, M.D. Executive Vice President, Research and Development, and Chief Medical Officer, Kite PharmaDr. David Chang has an industry-leading track record of innovation within oncology drug development. Most recently, he held senior leadership roles during his more than decade-long

tenure at Amgen, including a stint as vice president of global development and head of hematology-oncology. Dr. Chang spearheaded personalized therapy strategies underlying the success of a colon cancer drug at Amgen and ran the pivotal programs for a bispecific T-cell engager antibody in acute lymphocytic leukemia and for a first-of-its-kind oncolytic immunotherapy in melanoma. Dr. Chang’s areas of responsibility at Amgen included global regulatory interactions, product commercialization strategies, evaluation of business development opportunities and integration of key acquisitions. Prior to joining Amgen in 2002, Dr. Chang held dual appointments as associate professor of medicine and microbiology, immunology and molecular genetics at the David Geffen School of Medicine at UCLA. He obtained his bachelor’s in biology from the Massachusetts Institute of Technology and his M.D. and Ph.D. degrees from Stanford University. Dr. Chang also completed his internship and residency in internal medicine at Brigham and Women’s Hospital and his fellowship in medical oncology at Dana-Farber Cancer Institute at Harvard Medical School, where he was a Howard Hughes Medical Institute postdoctoral fellow.

SUDHEER DOSS, PH.D. Director, PwCSudheer Doss has 13 years of experience in the healthcare industry, focusing on operational strategy for entry into the emerging personalized medicine ecosystem. For the past eight years, his industry focus has been in the bio/pharmaceutical, diagnostics and life science tools industries. During

his tenure at PRTM/PwC, Doss has worked on a variety of projects, including operational due diligence, business launch strategies and various research and development innovation initiatives related to genomic medicine. More recently, he has supported the planning and launch of genomic medicine initiatives at several leading academic medical and cancer centers.

Prior to joining industry, Doss worked on genomics-based biomarker discovery during his doctorate and post-doctoral research at UCLA in the Department of Human Genetics. His research consisted of the development and application of genomics-based methods for the discovery of genes underlying complex diseases such as atherosclerosis and diabetes. Doss has pioneered computational methods that combine areas of network theory with genetics and global gene expression data to elucidate the pathways and genetic underpinnings of disease phenotypes.

JILL HAGENKORD, M.D. FCAP, Chief Medical Officer, 23andMeDr. Jill Hagenkord joined 23andMe in 2014 and serves as its chief medical officer, where she is responsible for all medical affairs activities, serving as the company liaison to physician, medical, genetics and research industry groups. Dr. Hagenkord also oversees laboratory, shipping and fulfillment

operations for the company.

Previously, she served as senior vice president of medical strategy for InVitae Corporation, a genetics information company. Prior to joining Invitae, she served as chief medical officer and senior vice president at Complete Genomics, Inc.

Dr. Hagenkord is a board-certified molecular genetic pathologist. She received her M.D. from Stanford University in 1999.

ALEXANDER HOFFMANN, PH.D. Professor, Microbiology and Immunology, UCLA Director, Institute for Quantitative and Computational BiosciencesAlexander Hoffmann is the Thomas M Asher Professor of Microbiology and Immunology at UCLA and the founding director of the Institute for Quantitative and Computational Biosciences.

Before joining UCLA in 2014, he was professor of biochemistry at University of California, San Diego, where he founded the San Diego Center for Systems Biology, co-founded the BioCircuits Institute and transformed the graduate program in bioinformatics and systems biology to span the computational biosciences from biomedical informatics to quantitative biology. He holds degrees in physics and zoology (B.A., Cambridge University), biochemistry and molecular biology (Ph.D., Rockefeller University) and owes his training to Robert Roeder and David Baltimore, as well as his many computational biology students.

MODERATOR ERIC VILAIN, PH.D. UCLA Professor of Human Genetics, Pediatrics and Urology at UCLACo-Director, Institute for Society and GeneticsChief of Medical Genetics, UCLA

Eric Vilain, M.D., Ph.D., earned his M.D. from the Paris Children’s Hospital Necker, his Ph.D. from the Pasteur

Institute in Paris, France, and then completed a postdoctoral fellowship in medical genetics at UCLA. He is a professor of human genetics, pediatrics and urology in the David Geffen School of Medicine at UCLA, the chief of medical genetics in the Department of Pediatrics, the co-director of the Institute for Society and Genetics and the co-director of the Clinical Genomics Center. His laboratory explores the genetics of sexual development, focusing on genetic and environmental determinants of what makes men and women different in their anatomy, behavior and susceptibility to disease. His research program has been continuously supported by several grants from the National Institutes of Health, and he has published extensively in the field of sexual development. He is a fellow of the American College of Medical Genetics.

In his recent State of the Union address, President Obama asserted that personalized medicine (aka “precision medicine”) will “bring us closer to curing diseases like cancer and diabetes… and keep ourselves and our families healthier.” In this panel, academic and industry experts discuss opportunities and challenges in the future of personalized medicine.



» PANEL 5: MOBILE HEALTH

ILANA MUHLSTEIN Registered Dietitian Nutritionist, UCLA Bruin Health Improvement ProgramIlana Muhlstein, R.D., is a registered dietitian nutritionist with a private practice in Los Angeles. She also works at UCLA, where she meets with occupational health patients and leads the Bruin Health Improvement Program.

Muhlstein acts as a nutrition consultant for several companies including Whole Foods Market, Curves, H2 Wellness Inc., and RIPE. In addition, she hosts and produces her own web TV series, titled Living Healthy Living Well on EmpowerMe.tv, and acts as the nutrition expert adviser for A&E’s upcoming new series, Fit2Fat2Fit. In addition, Ilana has worked in corporate wellness visiting large corporations and improving their in-house food offerings such as PIMCO, the Roll Company, Western Assets and Herbalife. She completed her Bachelors of Science degree from University of Maryland, and her Masters degree at North Eastern University.”

KOUROSH PARSAPOUR, M.D., MBA CEO, personalRNDr. Kourosh Parsapour is co-founder and CEO of personalRN, a digital health startup providing disease-specific inpatient education that is personalized to the needs of patients and their caregivers. He has over 15 years of clinical experience in pediatrics, emergency medicine and

critical care. Dr. Parsapour’s background in technology-enabled healthcare solutions started with his first faculty appointment at University of California, Davis in 2005. Since then, he has worked with clinicians, administrators and health policymakers to support the use and advancement of telehealth. His research and numerous publications in telemedicine culminated in his first startup, Telepeds. Specialists on Call, the leading provider of tele-stroke services, acquired Telepeds within its first year. Subsequent to his successful exit, he obtained his Healthcare Executive MBA from University of California, Irvine and remains very passionate about using innovative and relevant technology to improve the quality and accessibility of affordable healthcare.

DAVID J. WHELAN (’02) Co-Founder, STEMP Inc.David J. Whelan is a strategy consultant, operating executive and advisor building businesses and inspiring entrepreneurs at the intersection of technology, health and wellness. He is currently developing two digital health ventures, the STEMP™ Smart Temperature Patch and a stealth

data analytics company. Recent engagements include a multiyear strategic and financial plan for a leading synthetic biology organization and a commercialization strategy for a hospital-developed cancer diagnostic. He helped launch New York Genome Center, a unique not-for-profit scientific research institute. He was part of the team at 24 Hour Fitness that introduced an early consumer fitness wearable. A former retained executive search consultant, Whelan began his career with a biotechnology incubator in San Francisco. He holds an MBA with honors from UCLA Anderson and a B.S. in symbolic systems from Stanford University. He also studied at London Business School and Carnegie Mellon University.

MODERATOR MARK SCHWARTZ Founder, Launchpad Digital HealthMark Schwartz is a founder, general partner and managing director at Launchpad Digital Health (LDH), a seed-stage venture fund, providing co-location, mentoring and networking services in San Francisco. LDH partners with dynamic

management teams to build great, lasting companies. Prior to LDH, Schwartz spent more than 15 years in technology hardware, software, medical devices and life sciences. He co-founded Fabrinet, which provided optical technology, components for laser eye and skin surgeries, and anesthesia monitoring. as Bus Dev, GC, chief strategy officer; CFO 8 years and at IPO on NYSE in 2010 until 2012. He recently advised healthcare startups Pepex (glucose monitoring) and TIMMES (teleradiology, medical imaging data) and co-founded and advises Precision Converting Solutions (medical devices). Schwartz began his career as a corporate lawyer in Silicon Valley, specializing in mergers and acquisitions, licensing and other strategic transactions.

The panel will offer a perspective on the future landscape of mobile health solutions, and discuss how physicians plan to integrate and manage health information collected by their patients, the impact of regulation and the application of mobile health in emerging markets.



» PANEL 6: POLICY

After the election of a Republican majority to the U.S. Congress, this discussion will center on the future of the Affordable Care Act and other healthcare policy issues facing the United States today.

ALBERT LOWEY-BALL, PH.D. Health Economics and Medicaid Advisor, UC Berkeley School of Public HealthAlbert Lowey-Ball is a health economics and Medicaid advisor to the California Program on Access to Care (CPAC) at UC Berkeley School of Public Health. His responsibilities include analyses of Medicaid (Medi-Cal) and managed care expansion

and the Affordable Care Act’s (ACA, CoveredCA) implementation issues. CPAC’s mission is to address quality, access and cost issues faced by underserved communities in California. He is also president of Albert Lowey-Ball Associates, Inc. (ALBA), a health economics consulting firm. His primary clients are investment banks and venture capital firms and a network of independent practice associations, clinics, medical groups and hospitals. His work at CPAC focuses on the analyses of California’s health policy options within the framework of the ACA, including those related to healthcare mergers, rates and essential health benefits; impacts of Medicaid and managed care expansion; immigrant and rural healthcare coverage; viability of the Safety Net and implementation; and operation of health insurance exchanges. Lowey-Ball played a pioneering role in the development of Medi-Cal managed care plans and set up the first successful County Organized Health System — the Santa Barbara Health Initiative (CenCal Health Plan) — in the state. He also played a key role in establishing Care 1st Health Plan (now part of Health Net). He is a graduate of Rice and Georgetown and the University of Maryland and served as faculty in the masters programs in health policy and economics at the University of San Francisco for 21 years.

JONATHAN FIELDING, M.D., MPH, MBA Director and Professor-in-Residence, UCLA Fielding School of Public HealthDr. Jonathan E. Fielding, M.D., MPH, MBA has more than 30 years of experience working in various capacities in the areas of public health. He has recently retired after 16 years as the director of the Los Angeles County Department of Public Health.

Since 1979, Dr. Fielding has been a professor at the Schools of Public Health and Medicine at UCLA. From 1979 through 1984, he was the co-director for the Center for Health Enhancement, Education and Research. He chairs the HHS Secretary’s expert advisory group on the 2020 Healthy People Project, chairs the U.S. Community Preventive Services Task Force and is the editor of the Annual Review of Public Health. His current research interests are health impact assessment and forecasting future health. He received his medical degree and master’s in public health from Harvard University and an MBA from the University of Pennsylvania’s Wharton School of Business.

WENDY SCHIFFER, MSPH Director of Strategic Planning, L.A. Care Health PlanWendy Schiffer is the director of strategic planning for L.A. Care Health Plan, the nation’s largest public plan. L.A. Care provides care to more than 1.6 million members. Schiffer’s experience encompasses health services planning; health insurance outreach, enrollment and retention; and

enterprise-wide planning activities. Prior to joining L.A. Care, she served as director of Planning, Evaluation and Development for the Los Angeles County Department of Public Health, where she was responsible for the analyses of hospital demand; ambulatory care resource allocation; system planning under the County’s 1115 Waiver Medicaid Waiver; and HIV service planning. Schiffer holds an M.S. and B.A. in public health and history/sociology, respectively.

MODERATOR WESLEY YIN, PH.D. Associate Professor, UCLAWesley Yin is an associate professor in the Luskin School of Public Affairs and UCLA Anderson, and is a faculty research fellow at the National Bureau of Economic Research. Yin’s research interests are in the areas of health, economic development,

industrial organizations and public finance. His current research studies the relationship between economic growth and the formation of private markets; and how information, income and competitive forces impact the delivery of healthcare. Prior to coming to UCLA, Yin served as acting assistant secretary of economic policy at the Department of Treasury, and as a senior economist in the White House Council of Economic Advisers. He also taught at Boston University and the University of Chicago, and was a Robert Wood Johnson Scholar in Health Policy at Harvard University.



BRIAN WILLIAMS Director, PwCBrian Williams is a director at PwC who advises healthcare executives on strategy, innovation and corporate and entrepreneurial ventures. He has nearly 20 years of investment, business development and strategy expertise within healthcare. His work at PwC provides senior

executives with insights on market entry strategies, business model innovation and mHealth and eHealth strategy development and implementation. Prior to joining PwC, Williams served as an executive for two healthcare firms, including one early stage company where he quadrupled revenue in three years. He also drove industry acceptance and market growth of a venture-backed, Silicon Valley-based SaaS-deployed pharmaceutical data management and performance analytics firm. As an investor, Williams co-founded two top decile performing private equity funds as ranked by PwC’s MoneyTree report, whose investments included devices and diagnostics.

MODERATOR BILL COMANOR, PH.D. Professor of Health Policy and Management, Professor of Economics, UC Santa Barbara Director, Research Program on Pharmaceutical Economics and Policy, UCLAWilliam Comanor is a professor of health policy and management and a professor of economics at

the University of California, Santa Barbara. At UCLA, he is director of the Research Program on Pharmaceutical Economics and Policy and also organizes a seminar by the same name. Comanor received his Ph.D. in economics from Harvard University in 1964. Since completing his dissertation on “The Economics of Research and Development in the Pharmaceutical Industry,” he has written and lectured on various topics in this area and founded the Research Program he now directs. From 1991 through 1993, he served on the advisory panel of a federal government study on pharmaceutical research and development, and from 1978 through 1980, was chief economist and director of the Bureau of Economics at the U.S. Federal Trade Commission in Washington, D.C.

» PANEL 7: BIOPHARMA

After a year of biotech acquisitions, exploding stock prices, changes in government regulations and a globalizing biopharma market, what is in store for the life sciences industry?

STEPHANIE ASTROW, PH.D., MBA Vice President of Research and Development, Response Genetics

Stephanie Astrow is vice president of research and development for Response Genetics, a company focused on the development and commercialization of clinical diagnostic tests for cancer. In this role, she identifies opportunities for

new products, technologies and acquisitions to drive revenue in a highly competitive market sector. Prior to joining Response Genetics, Astrow was scientific director for oncology at Quest Diagnostics. At Quest, she played a key role in expanding business by introducing new assays and services as well as coordinating development strategy for companion diagnostics with key pharmaceutical companies. Prior to Quest, Astrow served as vice president of oncology at Pathway Diagnostics, and vice president and scientific director at Impath, Inc. Astrow received a bachelor’s in biology and medicine at Brown University and her Ph.D. in molecular and cell biology from the University of California, Berkeley. She also holds an MBA from Pepperdine University.

GUNJAN (MITAL) THIAGARAJAH (’05) Director, AmgenGunjan Thiagarajah is currently the marketing promotions lead for Vectibix in the oncology business unit. In this role, she has overseen the label expansion and growth of this biomarker driven therapeutic.

Prior to this role, she worked in payer and value marketing. She led a team that developed and executed the payer strategies for key Amgen products in the nephrology and oncology therapeutic areas. This included the creation of health-economic and value (FDAMA114) marketing resources. In this role, she also led the payer biosimilar strategy.

Thiagarajah joined Amgen in 2005 via the Commercial Leadership Program (CLP), starting as a sales representative in nephrology before transitioning to marketing roles. Early marketing experience included Enbrel Rheumatology as well as Access, where she developed the ENBREL patient support program. Prior to Amgen, Thiagarajah worked with Deloitte Consulting, where she enhanced business processes for claims and membership departments for large health insurance providers, designed new products and led HIPAA compliance initiatives.

She has a bachelor’s in electrical engineering from Rutgers University and an MBA from UCLA Anderson.


CAROL LEE THORPE, MBA Vice President of Programs and Services St. Barnabas Senior ServicesCarol Lee Thorpe is vice president of programs and services for St. Barnabas Senior Services, an organization providing a continuum of innovative services that empower a diverse community of elders to live well, feel well and age well. She is

responsible for strategic oversight of social services, healthcare, nutrition, transportation, wellness and longevity programs, community outreach and civic engagement. Thorpe also provides staff support to the Los Angeles Aging Advocacy Coalition and serves as an advisor for the implementation of California’s Coordinated Care Initiative.

Thorpe received her MBA from Pepperdine University in 1991. Throughout her career, she has held leadership positions with human services organizations and led the development of innovative healthcare and education programs.

Thorpe has devoted her career to providing creative leadership to health, social service and community service initiatives on behalf of vulnerable populations in California.

MODERATOR ARASH NAEIM, M.D., PH.D., Chief Medical Officer of Clinical Research and Geriatric Oncologist, UCLA HealthDr. Arash Naeim is a health professional whose career has spanned a combination of health services, informatics, health policy and quality of care issues. He currently serves as UCLA’s chief

medical officer for clinical research and associate professor of medicine in the divisions of hematology-oncology and geriatric medicine at the David Geffen UCLA School of Medicine. He is also director of two programs, the Geriatric-Oncology Research and Training Program and Hematology-Oncology Fellowship Program at UCLA. Additionally, Dr. Naeim holds multiple key organizational roles on campus, in the Cancer Center, within the Health System and for the Department of Medicine.

Dr. Naeim earned his B.S. in biochemistry and M.D. at the University of California, and received a Ph.D. in public policy from the RAND Corporation. His primary research focus is on breast cancer and his other research interests include outcomes research, cost-effectiveness analysis, modeling of health and frailty and clinical trial design.


» PANEL 8: BABY BOOMER SILVER TSUNAMI

SANDY ATKINS, MPA Vice President of Strategic Initiatives, Partners in Care FoundationSandy Atkins has over 30 years of experience planning and managing services for chronically ill adults. She is currently the vice president of strategic initiatives at Partners in Care Foundation, in charge of HomeMeds dissemination, consulting,

evaluation and new initiative development. Prior to joining Partners in Care, Atkins served as executive director of Hospice of Pasadena. At the USC Andrus Gerontology Center, she directed the Center for Long Term Care Integration, a state-funded effort to help counties integrate Medicare and Medicaid systems (both medical and long-term care services) for the aged, blind and disabled population. Atkins also directed the STARS Minnesota Rural Elder Services Community Initiative to help small towns plan services for their rapidly aging populations. Before that, she was administrator of several California continuing care retirement communities. Atkins has a master’s of public administration in long-term care administration, with a certificate in gerontology, from the University of Arizona, and a B.A. in Spanish from SUNY Buffalo.

SCOTT KAISER, M.D. Chief Innovation Officer, Motion Picture & Television FundDr. Scott Kaiser is a practicing geriatrician and chief innovation officer at the Motion Picture & Television Fund (MPTF), which provides services, support and assistance to the entertainment industry community. He is an advocate for the

improvement of aging services and geriatric care with a focus on better health and well-being through a community-oriented approach to the care of older adults. He believes in looking beyond healthcare to meet people where they are and where health happens: in their daily lives, with their friends and families, in their communities.

Dr. Kaiser received his medical degree from the Keck School of Medicine of USC. He went on to train within the Lawrence Family Medicine Residency, a program dedicated to the care of underserved populations. Following residency, he joined the Harvard Geriatric Medicine Fellowship, where he refined his clinical skills and began to apply his interest in health promotion to an older adult population while initiating research exploring the psychology of health behavior change. To further his expertise in this field, Dr. Kaiser returned to Los Angeles and joined the UCLA/VA Primary Care and Health Services Research Fellowship, where he served as a health media fellow. In this role, Dr. Kaiser partnered with the City of Los Angeles Department of Aging to produce broadcast media projects aimed at directly addressing the needs of older adults and ultimately improving their health and quality of life, including “On The Move,” a series following the lives of 12 L.A. seniors as they take on new challenges to become active, get fit, embrace a healthy lifestyle and enjoy all the rewards of their transformations.

By 2029, 20% of the US population will be over the age of 65 i.e. 1 in 5 Americans will be age 65 or older. What are the healthcare needs of the aging population? How is the healthcare system equipped to address the challenges imposed by the aging population?


» HBA CONFERENCE PANEL LEADS

PANEL 1: Payer/Provider — Alex Carey

PANEL 2: Emerging Markets — Margaret Threadgill & Joanne Zhang

PANEL 3: Medtech & Biodevice — Catherine Chen & Mona Mohindra

PANEL 4: Personalized Medicine — Daniel Croymans, Kevin Shah, & Brad Turner

PANEL 5: Mobile Health — Ankur Agarwal & Deb Dab

PANEL 6: Policy — Caitlyn Penny & Brendon Pezzack

PANEL 7: Pharma — Adam Foley & Ines Reygadas

PANEL 8: Baby Boomer Silver Tsunami — Tanu Bose & Bryan Pezeshki

http://bit.ly/1KwgAvT

Conference attendees recieve 20% discount on a 23andMe kit. Follow the link above!

Blu

e S

hie

ld o

f Ca

lifo

rnia

is a

n in

de

pe

nd

en

t me

mb

er

of t

he

Blu

e S

hie

ld A

sso

cia

tion

A

4786

9 (1

/15)

Blue Shield of California is proud to support the UCLA Anderson School of Management’s

Healthcare Business Association (HBA).

Guided by our not-for-profit values, we are committed to influencing positive change in our community and ensuring access to affordable, high-quality health

care for all Californians.

We are very pleased to be a sponsor of this year’s “Modernizing Healthcare for

the New Age” conference.

for care, not profit.TM

George Buckley, Conference Chair

Subodh Kolla, HBA President & Sponsorship Chair

Joel Lanzaga, Logistics & Operations Co-Chair

Steve Schumsky, Logistics & Operations Co-Chair

Ben Brockman, Marketing Chair

Fabienne Wen, Marketing Director

Rachel Newman, Business Development Co-Chair

Brendon Pezzack, Business Development (Products) Co-Director

Kevin Shah, Business Development (Products) Co-Director

Martin Wan, Business Development Co-Chair

Brian Ouyang, Business Development (Services) Co-Director

Bryan Pezeshki, Business Development (Services) Co-Director

Daniel Croymans, Outreach Chair

Brad Turner, Outreach Director

Kristin Andreassen, External Outreach Chair

Chad Kunert, External Outreach Director

Miao Wang, Information Technology Chair

Wenyuan Wu, Information Technology Director

UCLA Anderson School of Management

110 Westwood Plaza

Los Angeles, CA 90095-1481

andersonhba.com

PLATINUM

>> SPONSORS

>> HBA CONFERENCE TEAM:

GOLD:

BLUE:

CAMPUS AFFILIATES:

Special thanks to Easton Technology Development Program, Edwards Lifesciences, PwC and UCLA Anderson Office of the Dean

2015student hba conf program lr 2.6

Documents